NASS 2017 Annual Meeting

Sessions Speakers Exhibitors Products Press Releases Floor Plan Buzz

Speakers

Conor O'Neill, MD

Conor O'Neill, MD




Stock Ownership: Relievant (<1%), Nocimed (<1%).

Sessions :